ENTITY
Sirnaomics

Sirnaomics (2257 HK)

44
Analysis
Health Care • Hong Kong
Sirnaomics is an RNA therapeutics biopharmaceutical company that discovers and develops innovative drugs for indications with unmet medical needs. The company leverages its proprietary polypeptide nanoparticle (PNP) and GalNAc RNAi platforms (GalAhead™) to build a pipeline of drug candidates, including STP705 and STP707 for oncology and fibrosis, and STP122G for anticoagulant therapies. Headquartered in Gaithersburg, MD, United States, the company was founded in 2007.
more
•22 Jul 2022 11:34

Hong Kong Buybacks: AIA, Pop Mart, Great Wall Motor

We highlight the top 3 companies that repurchased the most shares from HK market in the past 7 days were Aia (1299 HK), Pop Mart (9992 HK), Great...

Logo
560 Views
Share
•21 Jun 2022 10:01

HSCI Index Rebalance and Stock Connect: Potential Changes in September

We see 28 potential adds and 9 close adds for the HSCI in September. There are 22 potential deletes on market cap, liquidity and prolonged...

Logo
1.3k Views
Share
•03 May 2022 06:12

HSCI Index Rebalance and Stock Connect: Potential Changes in June and September

We forecast 7 adds to the HSCI in June. For the September rebalance, we forecast 19 adds & 19 deletes (7 on mkt cap, 4 on liquidity, 8 on long...

Logo
922 Views
Share
bullish•SenseTime
•25 Jan 2022 08:58

HSCI Index Rebalance and Stock Connect: Plenty of New Listings Should Be Included

There could be up to 34 adds and 22 deletes for the HSCI in March based on market cap, liquidity and prolonged suspensions. A lot of new listings,...

Logo
807 Views
Share
•19 Dec 2021 09:48

ECM Weekly (19th December 2021) - LG Energy, Hyundai Engineering, Chervon, Sirnaomics, JG Mag A/H

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
546 Views
Share
x